Showing 1 - 20 results of 32 for search 'Megan Othus', सवाल का समय: 0.06सेकंड परिणाम को परिष्कृत करें
  1. 1
    Significance of Measurable Residual Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia

    Significance of Measurable Residual Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia द्वारा Margery Gang, Megan Othus, Roland B. Walter

    प्रकाशित 2025-02-01
    पूर्ण पाठ प्राप्त करें
    लेख
  2. 2
    Cytogenetic heterogeneity negatively impacts outcomes in patients with acute myeloid leukemia

    Cytogenetic heterogeneity negatively impacts outcomes in patients with acute myeloid leukemia द्वारा Bruno C. Medeiros, Megan Othus, Min Fang, Frederick R. Appelbaum, Harry P. Erba

    प्रकाशित 2015-03-01
    पूर्ण पाठ प्राप्त करें
    लेख
  3. 3
    Impact of body-mass index on the outcome of adult patients with acute myeloid leukemia

    Impact of body-mass index on the outcome of adult patients with acute myeloid leukemia द्वारा Bruno C. Medeiros, Megan Othus, Elihu H. Estey, Min Fang, Frederick R. Appelbaum

    प्रकाशित 2012-09-01
    पूर्ण पाठ प्राप्त करें
    लेख
  4. 4
    Influence of residual normal metaphases in acute myeloid leukemia patients with monosomal karyotype

    Influence of residual normal metaphases in acute myeloid leukemia patients with monosomal karyotype द्वारा Bin Xie, Megan Othus, Bruno C. Medeiros, Min Fang, Frederick R. Appelbaum, Elihu H. Estey

    प्रकाशित 2011-04-01
    पूर्ण पाठ प्राप्त करें
    लेख
  5. 5
    Effect of allogeneic hematopoietic cell transplantation in first complete remission on post-relapse complete remission rate and survival in acute myeloid leukemia

    Effect of allogeneic hematopoietic cell transplantation in first complete remission on post-relapse complete remission rate and survival in acute myeloid leukemia द्वारा Daisuke Araki, Megan Othus, Roland B. Walter, Vicky Sandhu, Brenda M. Sandmaier, Pamela S. Becker, Frederick R. Appelbaum, Elihu H. Estey

    प्रकाशित 2015-07-01
    पूर्ण पाठ प्राप्त करें
    लेख
  6. 6
    Improved outcomes with “7+3” induction chemotherapy for acute myeloid leukemia over the past four decades: analysis of SWOG trial data

    Improved outcomes with “7+3” induction chemotherapy for acute myeloid leukemia over the past four decades: analysis of SWOG trial data द्वारा Megan Othus, Guillermo Garcia-Manero, John E. Godwin, James K. Weick, Frederick R. Appelbaum, Harry P. Erba, Elihu H. Estey

    प्रकाशित 2022-07-01
    पूर्ण पाठ प्राप्त करें
    लेख
  7. 7
    Phase II trial of sorafenib in combination with carboplatin and paclitaxel in patients with metastatic uveal melanoma: SWOG S0512.

    Phase II trial of sorafenib in combination with carboplatin and paclitaxel in patients with metastatic uveal melanoma: SWOG S0512. द्वारा Shailender Bhatia, James Moon, Kim A Margolin, Jeffrey S Weber, Christopher D Lao, Megan Othus, Ana M Aparicio, Antoni Ribas, Vernon K Sondak

    प्रकाशित 2012-01-01
    पूर्ण पाठ प्राप्त करें
    लेख
  8. 8
    Regimen‐intensity per count‐recovery and hospitalization index: A new tool to assign regimen intensity for AML

    Regimen‐intensity per count‐recovery and hospitalization index: A new tool to assign regimen intensity for AML द्वारा Mohamed L. Sorror, Shirali Agarwal, Megan Othus, Ylinne Lynch, Jennifer E. Nyland, Mary‐Elizabeth Percival, Pamela S. Becker, Frederick R. Appelbaum, Elihu H. Estey

    प्रकाशित 2020-09-01
    पूर्ण पाठ प्राप्त करें
    लेख
  9. 9
    Relative impact of residual cytogenetic abnormalities and flow cytometric measurable residual disease on outcome after allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia

    Relative impact of residual cytogenetic abnormalities and flow cytometric measurable residual disease on outcome after allogeneic hematopoietic cell transplantation in adult acute... द्वारा Corentin Orvain, Jacob A. Wilson, Min Fang, Brenda M. Sandmaier, Eduardo Rodríguez-Arbolí, Brent L. Wood, Megan Othus, Frederick R. Appelbaum, Roland B. Walter

    प्रकाशित 2022-08-01
    पूर्ण पाठ प्राप्त करें
    लेख
  10. 10
    Relationship between event-free survival and overall survival in acute myeloid leukemia: a report from SWOG, HOVON/SAKK, and MRC/NCRI

    Relationship between event-free survival and overall survival in acute myeloid leukemia: a report from SWOG, HOVON/SAKK, and MRC/NCRI द्वारा Megan Othus, Wim van Putten, Bob Lowenberg, Stephen H. Petersdorf, Sucha Nand, Harry Erba, Frederick Appelbaum, Robert Hills, Nigel Russell, Alan Burnett, Elihu Estey

    प्रकाशित 2016-07-01
    पूर्ण पाठ प्राप्त करें
    लेख
  11. 11
    Measurable residual disease as predictor of post–day +100 relapses after allografting in adult AML

    Measurable residual disease as predictor of post–day +100 relapses after allografting in adult AML द्वारा Naveed Ali, Megan Othus, Eduardo Rodríguez-Arbolí, Corentin Orvain, Filippo Milano, Brenda M. Sandmaier, Chris Davis, Ryan S. Basom, Frederick R. Appelbaum, Roland B. Walter

    प्रकाशित 2025-02-01
    पूर्ण पाठ प्राप्त करें
    लेख
  12. 12
    Pulmonary function testing for fitness assessment in asymptomatic adults with newly diagnosed acute myeloid leukemia

    Pulmonary function testing for fitness assessment in asymptomatic adults with newly diagnosed acute myeloid leukemia द्वारा Raffaele Palmieri, Megan Othus, Guang-Shing Cheng, Francesco Buccisano, Giovangiacinto Paterno, Luca Maurillo, Maria Ilaria Del Principe, Giuseppe Sconocchia, Adriano Venditti, Roland B. Walter

    प्रकाशित 2022-08-01
    पूर्ण पाठ प्राप्त करें
    लेख
  13. 13
    Time independent factors that predict relapse in adults with acute myeloid leukemia

    Time independent factors that predict relapse in adults with acute myeloid leukemia द्वारा John J. Lim, Megan Othus, Carole M. Shaw, Kathryn Russell, Anna B. Halpern, Jacob S. Appelbaum, Paul Hendrie, Roland B. Walter, Elihu H. Estey, Mary-Elizabeth M. Percival

    प्रकाशित 2024-01-01
    पूर्ण पाठ प्राप्त करें
    लेख
  14. 14
    Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOG

    Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOG द्वारा Roland B. Walter, Megan Othus, Bob Löwenberg, Gert J. Ossenkoppele, Stephen H. Petersdorf, Thomas Pabst, Marie-Christiane Vekemans, Frederick R. Appelbaum, Harry P. Erba, Elihu H. Estey

    प्रकाशित 2015-10-01
    पूर्ण पाठ प्राप्त करें
    लेख
  15. 15
    Survival of patients with newly diagnosed high-grade myeloid neoplasms who do not meet standard trial eligibility

    Survival of patients with newly diagnosed high-grade myeloid neoplasms who do not meet standard trial eligibility द्वारा Mary-Elizabeth M. Percival, Megan Othus, Sarah Mirahsani, Kelda M. Gardner, Carole Shaw, Anna B. Halpern, Pamela S. Becker, Paul C. Hendrie, Mohamed L. Sorror, Roland B. Walter, Elihu H. Estey

    प्रकाशित 2020-07-01
    पूर्ण पाठ प्राप्त करें
    लेख
  16. 16
    Contribution of measurable residual disease status to prediction accuracy of relapse and survival in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation

    Contribution of measurable residual disease status to prediction accuracy of relapse and survival in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell tra... द्वारा Eduardo Rodríguez-Arbolí, Megan Othus, Corentin Orvain, Lucas C. Zarling, Brenda M. Sandmaier, Filippo Milano, Gary Schoch, Chris Davis, H. Joachim Deeg, Frederick R. Appelbaum, Rainer Storb, Roland B. Walter

    प्रकाशित 2022-09-01
    पूर्ण पाठ प्राप्त करें
    लेख
  17. 17
    Phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: adrenocortical carcinoma cohort

    Phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: adrenocortical carcinoma cohort द्वारा Howard Streicher, Elad Sharon, Razelle Kurzrock, Young Kwang Chae, Benjamin Tan, Megan Othus, Christine McLeod, Charles Blanke, Helen X Chen, Sandip P Patel, Gabby Lopez, Tridu Huynh, Timothy Kuzel, Christopher W Ryan

    प्रकाशित 2024-07-01
    पूर्ण पाठ प्राप्त करें
    लेख
  18. 18
    Quantification of measurable residual disease using duplex sequencing in adults with acute myeloid leukemia

    Quantification of measurable residual disease using duplex sequencing in adults with acute myeloid leukemia द्वारा Laura W. Dillon, Jake Higgins, Hassan Nasif, Megan Othus, Lan Beppu, Thomas H. Smith, Elizabeth Schmidt, Charles C. Valentine III, Jesse J. Salk, Brent L Wood, Harry P. Erba, Jerald P. Radich, Christopher S. Hourigan

    प्रकाशित 2023-08-01
    पूर्ण पाठ प्राप्त करें
    लेख
  19. 19
    Unsatisfactory efficacy in randomized study of reduced-dose CPX-351 for medically less fit adults with newly diagnosed acute myeloid leukemia or other high-grade myeloid neoplasm

    Unsatisfactory efficacy in randomized study of reduced-dose CPX-351 for medically less fit adults with newly diagnosed acute myeloid leukemia or other high-grade myeloid neoplasm द्वारा Roland B. Walter, Megan Othus, Kaysey F. Orlowski, Emily N. McDaniel, Bart L. Scott, Pamela S. Becker, Mary-Elizabeth M. Percival, Paul C. Hendrie, Bruno C. Medeiros, Michael T. Chiarella, Arthur C. Louie, Elihu H. Estey

    प्रकाशित 2018-03-01
    पूर्ण पाठ प्राप्त करें
    लेख
  20. 20
    Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis

    Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis द्वारा Sarah A. Buckley, Brent L. Wood, Megan Othus, Christopher S. Hourigan, Celalettin Ustun, Michael A. Linden, Todd E. DeFor, Michele Malagola, Chloe Anthias, Veronika Valkova, Christopher G. Kanakry, Bernd Gruhn, Francesco Buccisano, Beth Devine, Roland B. Walter

    प्रकाशित 2017-05-01
    पूर्ण पाठ प्राप्त करें
    लेख

खोज साधन: